CONCERT GENETIC TESTING: HEMATOLOGIC CONDITIONS (NONCANCEROUS)
Customize your policy alerts
Sign up for all carolinabehavioralhealth policy alerts
Know when carolinabehavioralhealth releases new policies or updates existing guidance.
Monitor payer policy activity
Medical-necessity criteria for genetic testing to confirm or establish diagnoses of inherited thrombophilia, hemoglobinopathies, hemophilia A or B, von Willebrand disease, and other noncancerous hematologic conditions.
The policy revision updated the coding, reference table, background, and references.
The policy revision removed F8 Sequencing Analysis from the hemophilia policy reference table.
The V1.2025 revision updated the G6PD, hemophilia, von Willebrand disease, inherited thrombophilia, and hemoglobinopathy sections and references.
Criteria for known familial variant analysis in noncancerous hematologic conditions were moved to the general genetic and molecular testing policy.
The policy title was updated to reflect the V1.2025 version during the November 2024 semi-annual review.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.